Skip to main content
SpringerLink
Log in

Case 5

  • Chapter
Atlas of Hematologic Neoplasms

  • 1917 Accesses

A 62-year-old man presented with transient ischemic accident with resultant speech defects and left-sided weakness lasting for less than 24 h.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Thiele J, Kvasnicka HM, Orazi A, et al. Essential thrombocythaemia. In Swerdlow SH, Campo E, Harris NL, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France, IARC Press, 2008, 48–50.

    Google Scholar 

  2. Tefferi A, Thiele J, Orazi A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: Recommendations from an ad hoc international expert panel. Blood 2007;110:1092–1097.

    Google Scholar 

  3. Terreri A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008;22:14–22.

    Article  Google Scholar 

  4. Thiele J, Kvasnicka HM, Zankovich R, et al. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis. Haematologica 2000;85:1126–1134.

    CAS  PubMed  Google Scholar 

  5. Schafer AI. Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia. Blood 2006;107:4214–4222.

    Article  CAS  PubMed  Google Scholar 

  6. Pikman Y, Levine RL. Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders. Curr Opin Oncol 2007;19:628–634.

    Article  CAS  PubMed  Google Scholar 

  7. Tefferi A. Essential thrombocythemia: Scientific advances and current practice. Curr Opin Hematol 2006;13:93–98.

    Article  PubMed  Google Scholar 

  8. Elliott MA, Tefferi A. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol 2004;128:275–290.

    Article  Google Scholar 

Download references

Editor information

Editors and Affiliations

  1. Director of Hematopathology and Flow Cytometry Pathology and Laboratory Medicine Service Veterans Affairs Medical Center Eastern Colorado Health Care System Professor of Pathology Department of Pathology, University of Colorado School of Medicine, 80220, Denver, Colorado, USA

    Tsieh Sun M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

(2009). Case 5. In: Sun, T. (eds) Atlas of Hematologic Neoplasms. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-89848-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-89848-3_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-89847-6

  • Online ISBN: 978-0-387-89848-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation